Corynebacterium diphtheriae

This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.

Identification

Brand Names
Prevnar 13
Generic Name
Corynebacterium diphtheriae
DrugBank Accession Number
DB09877
Background

Corynebacterium diphtheriae toxin is extracted from the pathogenic actinobacterium C. diphtheriae that causes diphtheria. The bacteria culture is grown in a medium and through purification, diphtheria toxin is detoxified with formaldehyde and diafiltered. The vaccine is intramuscularly administered to provide active immunization against diphtheria in infants and children.

Type
Biotech
Groups
Approved, Investigational
Biologic Classification
Vaccines
Other vaccines
Synonyms
Not Available

Pharmacology

Indication

Not Available

Reduce drug development failure rates
Build, train, & validate machine-learning models
with evidence-based and structured datasets.
See how
Build, train, & validate predictive machine-learning models with structured datasets.
See how
Associated Conditions
Indication TypeIndicationCombined Product DetailsApproval LevelAge GroupPatient CharacteristicsDose Form
Used in combination to preventDiphtheriaCombination Product in combination with: Clostridium tetani (DB09876)•••••••••••••••••••••• ••••••••••
Prevention ofDiphtheria••••••••••••
Used in combination for prophylaxis ofTetanusCombination Product in combination with: Clostridium tetani (DB09876)••••••••••••••••••••• •••••••••••••••••• ••••••••••
Used in combination to preventTetanusCombination Product in combination with: Clostridium tetani (DB09876)•••••••••••••••••••••• ••••••••••
Prevention ofTetanus••••••••••••
Contraindications & Blackbox Warnings
Prevent Adverse Drug Events Today
Tap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.
Learn more
Avoid life-threatening adverse drug events with our Clinical API
Learn more
Pharmacodynamics

Not Available

Mechanism of action
Not Available
Absorption

Not Available

Volume of distribution

Not Available

Protein binding

Not Available

Metabolism
Not Available
Route of elimination

Not Available

Half-life

Not Available

Clearance

Not Available

Adverse Effects
Improve decision support & research outcomes
With structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!
See the data
Improve decision support & research outcomes with our structured adverse effects data.
See a data sample
Toxicity

Not Available

Pathways
Not Available
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
Not Available
Food Interactions
Not Available

Products

Drug product information from 10+ global regions
Our datasets provide approved product information including:
dosage, form, labeller, route of administration, and marketing period.
Access now
Access drug product information from over 10 global regions.
Access now
Mixture Products
NameIngredientsDosageRouteLabellerMarketing StartMarketing EndRegionImage
Boostrix Injektionssuspension in einer FertigspritzeCorynebacterium diphtheriae (2 IU) + Bordetella pertussis filamentous hemagglutinin antigen (formaldehyde inactivated) (8 μg) + Bordetella pertussis pertactin antigen (2.5 μg) + Clostridium tetani (20 IU) + Pertussis vaccine (8 μg)Injection, suspensionIntramuscularGlaxo Smith Kline Pharma Gmb H2001-02-16Not applicableAustria flag
Boostrix Polio - Injektionssuspension in einer FertigspritzeCorynebacterium diphtheriae (2 IU/0.5ml) + Bordetella pertussis filamentous hemagglutinin antigen (formaldehyde inactivated) (8 mcg/0.5ml) + Bordetella pertussis pertactin antigen (2.5 mcg/0.5ml) + Clostridium tetani (20 IU/0.5ml) + Pertussis vaccine (8 mcg/0.5ml) + Poliovirus type 1 antigen (formaldehyde inactivated) (40 [D'ag'U]/0.5ml) + Poliovirus type 2 antigen (formaldehyde inactivated) (8 [D'ag'U]/0.5ml) + Poliovirus type 3 antigen (formaldehyde inactivated) (32 [D'ag'U]/0.5ml)Injection, solutionIntramuscularGlaxo Smith Kline Pharma Gmb H2004-11-05Not applicableAustria flag
Infanrix-IPV+Hib Pulver und Suspension zur Herstellung einer InjektionssuspensionCorynebacterium diphtheriae (30 IU/0.5ml) + Bordetella pertussis filamentous hemagglutinin antigen (formaldehyde inactivated) (25 mcg/0.5ml) + Bordetella pertussis pertactin antigen (8 mcg/0.5ml) + Clostridium tetani toxoid antigen (formaldehyde inactivated) (40 IU/0.5ml) + Haemophilus influenzae b polysaccharide-tetanus conjugate (10 mcg/0.5ml) + Pertussis vaccine (25 mcg/0.5ml) + Poliovirus type 1 antigen (formaldehyde inactivated) (40 [D'ag'U]/0.5ml) + Poliovirus type 2 antigen (formaldehyde inactivated) (8 [D'ag'U]/0.5ml) + Poliovirus type 3 antigen (formaldehyde inactivated) (32 [D'ag'U]/0.5ml)Injection, powder, for suspensionIntramuscularGlaxo Smith Kline Pharma Gmb H2010-06-04Not applicableAustria flag
MENJUGATECorynebacterium diphtheriae (18.75 mcg/0.5mL) + Meningococcal polysaccharide vaccine group C (10 mcg/0.5mL)Injection, suspensionIntramuscularGlaxosmithkline Vaccines S.R.L.2015-07-16Not applicableItaly flag
MENJUGATECorynebacterium diphtheriae (18.75 mcg/0.5mL) + Meningococcal polysaccharide vaccine group C (10 mcg/0.5mL)Injection, suspensionIntramuscularGlaxosmithkline Vaccines S.R.L.2015-07-16Not applicableItaly flag

Categories

Drug Categories
Classification
Not classified
Affected organisms
Not Available

Chemical Identifiers

UNII
3U7E3O07S8
CAS number
Not Available

References

General References
Not Available
PubChem Substance
347910466
Wikipedia
Corynebacterium_diphtheriae

Clinical Trials

Clinical Trials

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage Forms
FormRouteStrength
Injection, solutionIntramuscular
Injection, powder, for suspensionIntramuscular
Injection, suspensionIntramuscular
SuspensionIntramuscular
InjectionIntramuscular
Prices
Not Available
Patents
Not Available

Properties

State
Not Available
Experimental Properties
Not Available

Drug created at November 30, 2015 21:23 / Updated at June 12, 2020 16:52